Panaxium COO Jonathan Balfour presents novel brain machine interface device platform at OBIO Investment Summit 2023 in Toronto, Canada.
Author: Angela Bourne
Dr. Gilles Huberfeld to Lead First In-Human Trial of Panaxium’s Next-Generation Brain Computer Interface
Dr. Gilles Huberfeld, MD, PhD, is leading the 1st humans patient investigations of Panaxium’s next-generation iontronic brain computer interface in 2023 in Paris, France.
Panaxium Wins 1st Place Jury Prize at 2022 Brain Innovation Days
Panaxium won the 2022 Brain Innovation Days 1st Place Jury Prize at the conference’s pitch competition held in Brussels, Belgium, on October 12, 2022.